Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview
- PMID: 27366355
- PMCID: PMC4927134
- DOI: 10.5455/jice.20160530032814
Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview
Abstract
Chinese herbal medicine (CHM) is an integral component of complementary/alternative medicine and it is increasingly becoming the preferred therapeutic modality for the treatment of liver fibrosis and hepatocellular carcinoma (HCC) worldwide. Accordingly, the World Health Organization (WHO) has attested to the popularity and efficacy of indigenous herbal therapies including CHM as a first line of treatment for some diseases including liver disorders. However, the WHO and drug discovery experts have always recommended that use of indigenous herbal remedies must go hand-in-hand with the requisite mechanistic elucidation so as to constitute a system of verification of efficacy within the ethnobotanical context of use. Although many CHM experts have advanced knowledge on CHM, nonetheless, more enlightenment is needed, particularly mechanisms of action of CHMs on fibro-hepato-carcinogenesis. We, herein, provide in-depth mechanisms of the action of CHMs which have demonstrated anti-fibro-hepatocarcinogenic effects, in pre-clinical and clinical studies as published in PubMed and other major scientific databases. Specifically, the review brings out the important signaling pathways, and their downstream targets which are modulated at multi-level by various anti-fibro-hepatocarcinogenic CHMs.
Keywords: Chinese herbal medicine; fibro-hepato-carcinogenesis; immunomodulation; inflammation; mechanistic elucidation.
Conflict of interest statement
Figures


Similar articles
-
Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.J Ethnopharmacol. 2013 Oct 7;149(3):601-12. doi: 10.1016/j.jep.2013.07.030. Epub 2013 Aug 1. J Ethnopharmacol. 2013. PMID: 23916858 Review.
-
Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: A systematic review.J Ethnopharmacol. 2021 Mar 25;268:113561. doi: 10.1016/j.jep.2020.113561. Epub 2020 Nov 4. J Ethnopharmacol. 2021. PMID: 33157222
-
Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database.BMC Complement Altern Med. 2017 Feb 20;17(1):118. doi: 10.1186/s12906-017-1628-0. BMC Complement Altern Med. 2017. PMID: 28219357 Free PMC article.
-
Effects and mechanisms of Chinese herbal medicine on IgA nephropathy.Phytomedicine. 2023 Aug;117:154913. doi: 10.1016/j.phymed.2023.154913. Epub 2023 Jun 5. Phytomedicine. 2023. PMID: 37307737 Review.
-
Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice.Chin Herb Med. 2023 Sep 4;15(4):485-495. doi: 10.1016/j.chmed.2023.05.003. eCollection 2023 Oct. Chin Herb Med. 2023. PMID: 38094009 Free PMC article. Review.
Cited by
-
Evodiamine ameliorates liver fibrosis in rats via TGF-β1/Smad signaling pathway.J Nat Med. 2018 Jan;72(1):145-154. doi: 10.1007/s11418-017-1122-5. Epub 2017 Sep 21. J Nat Med. 2018. PMID: 28936800
-
Hepato-protective effects of Glossogyne tenuifolia in Streptozotocin-nicotinamide-induced diabetic rats on high fat diet.BMC Complement Altern Med. 2019 Jun 6;19(1):117. doi: 10.1186/s12906-019-2529-1. BMC Complement Altern Med. 2019. PMID: 31170991 Free PMC article.
-
Reparative and toxicity-reducing effects of liposome-encapsulated saikosaponin in mice with liver fibrosis.Biosci Rep. 2020 Aug 28;40(8):BSR20201219. doi: 10.1042/BSR20201219. Biosci Rep. 2020. PMID: 32756863 Free PMC article.
-
Anti-Fatigue and Exercise Performance Improvement Effect of Glossogyne tenuifolia Extract in Mice.Nutrients. 2022 Feb 27;14(5):1011. doi: 10.3390/nu14051011. Nutrients. 2022. PMID: 35267986 Free PMC article.
References
-
- Song YN, Sun JJ, Lu YY, Xu LM, Gao YQ, Zhang W, et al. Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: A multicenter double-blind randomized controlled trail. Evid Based Complement Alternat Med. 2013;2013:709305. - PMC - PubMed
-
- Liu HX, Wang SR, Lei Y, Shang JJ. Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction. J Tradit Chin Med. 2011;31:269–72. - PubMed
-
- Wang Q, Kuang H, Su Y, Sun Y, Feng J, Guo R, et al. Naturally derived anti-inflammatory compounds from Chinese medicinal plants. J Ethnopharmacol. 2013;146:9–39. - PubMed
-
- Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38. - PubMed
-
- Wu Q, Qin SK. Features and treatment options of Chinese hepatocellular carcinoma. Chin Clin Oncol. 2013;2:38. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources